Skip to main content

First big drugs for 2024

New treatments for NASH, schizophrenia and more are on the way.

Welcome to the first Drug Pipeline Insights Report for 2024

Read the report for a review of:

  • First approved drug for negative symptoms of schizophrenia
  • First-in-class treatment for pulmonary arterial hypertension
  • First FDA-approved drug for nonalcoholic steatohepatitis (NASH).

Download now

Don't want to read the full report? View the summary.

View summary

Find out what Optum Rx has to offer

Related content

Optum Rx Drug Pipeline Insights Reports

Read the most recent quarterly reports on new drugs coming down the pipeline.

3 ways to deal with escalating drug costs

Innovations custom built for today’s specialty challenges.

Transforming the pharmacy industry with transparency

Hear how the industry’s most transparent and independent Pharmacy & Therapeutics Committee evaluates drugs for the Optum Rx formulary.